Quantcast
Last updated on April 17, 2014 at 14:57 EDT

Latest hyperglycemia Stories

2011-11-14 11:17:36

Maintaining normal blood glucose levels prevents long-term kidney complications Highlights:     People with type 1 diabetes are at high risk of developing kidney disease.     Intensive diabetes therapy can preserve kidney function in patients with type 1 diabetes.     Between one million and three million Americans may have type 1 diabetes. Each year, more than 15,000 children and 15,000 adults - approximately 80 people per day - are...

2011-11-08 21:28:03

Study finds that insulin resistance is associated with inflammatory processes that lead to cortical atrophy and brain dysfunction Many complications of diabetes, including kidney disease, foot problems and vision problems are generally well recognized. But the disease's impact on the brain is often overlooked. For the past five years, a team led by Beth Israel Deaconess Medical Center (BIDMC) neurophysiologist Vera Novak, MD, PhD, has been studying the effects of diabetes on cognitive...

2011-11-02 06:00:00

CARLSBAD, Calif., Nov. 2, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it has initiated Phase 1 clinical studies for ISIS-GCGRRx and ISIS-GCCRRx, antisense drugs Isis is developing for the treatment of type 2 diabetes. Isis will develop both ISIS-GCGRRx and ISIS-GCCRRx to treat a broad population of diabetic patients. The unique mechanism of action of these new drugs could allow each drug to be used in combination with other therapies for type 2...

2011-10-05 22:05:42

Research also indicates reduction in intake of food toxins improves diabetes in adults Researchers from Mount Sinai School of Medicine have found high levels of food toxins called Advanced Glycation End products (AGEs) in infants. Excessive food AGEs, through both maternal blood transmission and baby formula, could together significantly increase children's risk for diseases such as diabetes from a very young age. A second study of AGEs in adults found that cutting back on processed,...

2011-09-29 05:52:51

(Ivanhoe Newswire) -- People with type 2 diabetes who intensively lower their blood sugar are not preventing cognitive decline, according to new research. Individuals with type 2 diabetes who are older than age 70 are twice as likely to develop cognitive impairment that is linked to their disease than those without diabetes. A team of researchers studied nearly 3,000 patients aged 55 years who had type 2 diabetes and were at risk for cardiovascular disease. These individuals also had...

2011-09-28 15:04:04

Researchers at the John G. Rangos Sr. Research Center at Children's Hospital of Pittsburgh of UPMC and the University of Pittsburgh School of Medicine have identified a powerful molecular pathway that regulates the liver's management of insulin and new glucose production, which could lead to new therapies for diabetes. The findings were published online this week in Diabetes, a journal of the American Diabetes Association. Usually, the liver stores excess blood sugar as glycogen, which it...

2011-09-19 06:00:00

HAYWARD, Calif., Sept. 19, 2011 /PRNewswire/ -- OptiScan Biomedical Corporation, a developer of innovative continuous glucose monitoring systems for use in intensive care units (ICU), today announced that the company's OptiScanner(TM) Automatic Bedside Glucose Monitoring System has received CE Mark certification for use in the European Union. This CE Mark certifies that the OptiScanner has met all relevant European Union consumer safety, health and environmental requirements, allowing it...

2011-09-15 10:01:00

MOUNTAIN VIEW, Calif., Sept. 15, 2011 /PRNewswire/ -- ChemoCentryx, Inc. today announced that the Company's novel, orally active CCR2 antagonist, CCX140-B, demonstrated an excellent safety profile and exhibited clear signs of biological and clinical effect in a Phase II study in patients with type 2 diabetes on stable doses of metformin. While demonstrating safety and tolerability, a statistically significant decrease in hemoglobin A1c (HbA1c) relative to placebo and a dose-dependent...

2011-09-08 07:00:00

PHILADELPHIA, Sept. 8, 2011 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing the Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery, today announced that it is initiating a clinical study of its Symphony tCGM System. The company expects to complete and announce the results of the study in the near-term. "Initiating the clinical study of...

2011-09-05 11:40:18

Study finds inflammation may be part of the solution, not the problem Increased low-grade inflammation in the body resulting from obesity is widely viewed as contributing to type 2 diabetes. Going against this long-held belief, researchers from Children's Hospital Boston report that two proteins activated by inflammation are actually crucial for maintaining good blood sugar levels — and that boosting the activity of these proteins can normalize blood sugar in severely obese and...